Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Nov 21.
Published in final edited form as: European J Org Chem. 2009 Sep;2009(27):10.1002/ejoc.200900694. doi: 10.1002/ejoc.200900694

Temporary Protection of H-Phosphinic Acids as a Synthetic Strategy

Laëtitia Coudray a, Jean-Luc Montchamp a,
PMCID: PMC3836261  NIHMSID: NIHMS524481  PMID: 24273443

Abstract

H-Phosphinates obtained through various methodologies are protected directly via reaction with triethyl orthoacetate. The resulting products can be manipulated easily, and various synthetic reactions are presented. For example, application to the synthesis of aspartate transcarbamoylase (ATCase) or kynureninase inhibitors are illustrated.

Other reactions, such as Sharpless’ asymmetric dihydroxylation, or Grubbs’ olefin cross-metathesis are also demonstrated.

Keywords: Phosphorus, Palladium, Metathesis, Cross-Coupling, Synthesis

Introduction

Gallagher, and soon afterwards chemists at Ciba-Geigy (formerly) have introduced and developed an ingenious family of reagents in which one P-H bond of hypophosphorous acid (HPA, H3PO2, 1) is masked temporarily and then re-introduced in a later step.[1] This allows selective reactions and solves the problem of disubstitution of the two reactive P-H bonds in HPA. We have been referring to these reagents as “Ciba-Geigy reagents” [ethyl 1,1-(diethoxyethyl)- and 1,1-(diethoxymethyl)-H-phosphinates, RC(OEt)2P(O)(OEt)H, R = Me, H; 2 and 3, respectively], in keeping with their historical origins. Reagents 2 and 3 have permitted the synthesis of many phosphinic acid derivatives through alkylation, and they have been used rather extensively.[2] Reagent 2 is often superior to reagent 3 because cleavage of the acetal functionality takes place under milder conditions and without cleavage of the P(O)OEt ester group.[1d]

graphic file with name nihms524481u1.jpg

Over the past ten years, we have developed several reactions for the synthesis of H-phosphinates, directly from hypophosphorous precursors (HPA, anilinium and sodium hypophosphites, alkyl phosphinates, etc.).[3] Many of these reactions provide an environmentally benign access to H-phosphinates, because halogenated compounds and/or stoichiometric strong bases are avoided, the reactions proceed with low loadings of transition-metal catalysts or with a radical initiator, and either no by-product is created (addition/hydrophosphinylation) or water is formed (condensation/cross-coupling). As a result, many H-phosphinates are now accessible directly, through routes unavailable to the Ciba-Geigy reagents. However, H-phosphinates are often not compatible with many reactions (oxidation/reduction, etc.) that would modify the carbon chain, so a temporary protection scheme is sometimes necessary. We recently reported one solution to this problem, based on borane complexes.[4] Since our methodologies provide compounds which cannot be made easily (or efficiently) from reagents 2 or 3, we decided to investigate a protection strategy based on acetals. Perhaps surprisingly, few reports have described the reaction of H-phosphinates with orthoesters. There is only one reference that describes the reaction of a single H-phosphinic acid with triethyl orthoformate,[5] and none with triethyl orthoacetate (Table 1).

Table 1.

Literature references to access protected phosphinates.[a]

H3PO2 R2PCl RPO2H2 RP(O)(OR1)H
(EtO)3CH 1 7 5 1a, 1b, 8
(EtO)3CMe 1 7 this work 1g, 9
H2C=C(OEt)2 6 - - 10
TIPSCl/BH3 4 - 4 4
[a]

see References.

During the synthesis of an aspartate transcarbamoylase (ATCase) inhibitor, we recently were confronted with the need to protect cinnamyl-H-phosphinic acid before an ozonolysis step, and we successfully employed triethyl orthoacetate to prepare 4 in excellent yield (Eq 1).[11] We realized that this strategy would be synthetically useful, and this prompted the present study on the direct synthesis of various ethyl (1,1-diethoxyethyl)phosphinates from H-phosphinic acids, and some of their reactivity.

graphic file with name nihms524481e1.jpg (1)

Herein, we report on the reaction of H-phosphinic acids with triethyl orthoacetate, as well as some subsequent transformations not previously exploited in the literature. The synthetic transformations illustrated include oxidations (ozonolysis, epoxidation, Sharpless’ asymmetric dihydroxylation), reductions (hydrogenation, hydroboration), Buchwald-Hartwig amination, and olefin cross-metathesis. All these reactions are not compatible with free P-H bonds, at least in our hands.

Results and Discussion

The advantages of our strategy (Scheme 1), over the use of the Ciba-Geigy reagents, stems from the much wider availability of H-phosphinates 5 using our methodologies, as well as the more practical nature of using triethyl orthoacetate on H-phosphinates 5 instead of HPA 1, or the simpler purification of the products 5 as opposed to purifying 2 and 3. Thus, although the two strategies are only differing in the order of the steps, the limited transformations available from 2 (or 3) to compounds 6 are narrowing the scope of these reagents. For example, 2 and 3 can be alkylated using a strong base and an electrophile, they can be silylated and alkylated, and some cross-coupling chemistry has been reported (with high loadings of palladium catalyst).

Scheme 1.

Scheme 1

Strategies for the synthesis of protected phosphinates. R1 = H, Me; R2 = H, Et; R3 = TIPS, Et. [a] (i) TIPSCl/Et3N (1.5/1.6 equiv.), CH3CN, 0 °C to r.t., 14 h; (ii) BH3 • Me2S (2.0 equiv.), CH3CN, r.t., 5 h.

Even our protecting strategy based on phosphonite-borane complexes 7 obtained either from 5 or 9 (Scheme 1),[4] is not competitive since, for example, the simple hydrogenation of an alkene is sluggish (Eq 2), and if the same reaction is conducted in methanol, decomplexation of the borane takes place exclusively.

graphic file with name nihms524481e2.jpg (2)

The protection of dichlorophosphines 8 (Scheme 1 and Table 1) has been used, especially with ClCH2PCl2, but the lack of availability of these compounds is a significant limitation (in fact, 8 can be made from 5, R2 = H).

1. Synthesis of phosphinate acetals 6 from H-phosphinates 5

Since the reaction of H-phosphinic acids with triethyl orthoacetate has not been described previously,[12] we decided to investigate its scope. Table 2 shows the results of this study. All the substrates are readily available through various methodologies we have developed. Isolated yields of protected acetals range from moderate to good (41–80%) for a wide range of functionalized substrates.

Table 2.

Protection of H-phosphinates

Entry Phosphinate Conditions[a] Yield (%)[b]
1 graphic file with name nihms524481t1.jpg A 80
B 60
C 37[c]
2 graphic file with name nihms524481t2.jpg A 67
B 20[c]
3 graphic file with name nihms524481t3.jpg A 64
4 graphic file with name nihms524481t4.jpg A 50
5 graphic file with name nihms524481t5.jpg A 53
6 graphic file with name nihms524481t6.jpg A 50
7 graphic file with name nihms524481t7.jpg A 55
8 graphic file with name nihms524481t8.jpg A 41
9 graphic file with name nihms524481t9.jpg A 74
10 graphic file with name nihms524481t10.jpg A 69
11 graphic file with name nihms524481t11.jpg A 60
12 graphic file with name nihms524481t12.jpg A 76
13 graphic file with name nihms524481t13.jpg D 58[d]
E 74[d]
[a]

Method A: BF3•Et2O (0.2 or 0.5 equiv.), CH3C(OEt)3 (6.0 equiv.), r.t., N2, 16–24 h; Method B: HC(OEt)3 (60 equiv.), reflux, N2, 24 h; Method C: Yb(OTf)3 (3 mol-%), CH3C(OEt)3 (6.0 equiv.), THF (0.4 M), r.t., N2, 22 h; Method D: BF3•Et2O (1.0 equiv.), CH3C(OEt)3 (6.0 equiv.), r.t., N2, 4 h then at 0°C, pyridine (10.0 equiv.) and Ac2O (5.0 equiv.), r.t., N2, 4 h; Method E: Yb(OTf)3 (3 mol-%), CH3C(OEt)3 (6.0 equiv.), r.t., N2, 3 h then at 0°C, pyridine (10.0 equiv.) and Ac2O (5.0 equiv.), r.t., N2, 4 h.

[b]

Isolated yields (unless otherwise noted).

[c]

NMR yield.

[d]

Acetate.

As described for other phosphinylidene-containing compounds, BF3•Et2O in a sub-stoichiometric amount was satisfactory in general (Method A, Table 1). In some cases, a small amount of ytterbium triflate also gave good results, especially in hydroxy-containing substrates. In this case, some acetate is directly obtained as a mixture with the alcohol, so acetylation was conducted on the crude reaction mixture. With alcohol-containing substrates, partial esterification was observed, and acetylation was conducted to drive the reaction to completion (Method E). With BF3•Et2O, a full equivalent was used for alcohols (Method D).

Triethyl orthoformate is less satisfactory (Method B), but only useful in cases where the H-phosphinic acid intermediate is ultimately desired because selective deprotection is problematic.[2] Attempts at using the literature condition (p-TsOH)[5], or BF3•Et2O, did not give good results

2. Synthetic applications with compounds 6

Several reactions were tried on protected ethyl H-phosphinates 6 (Schemes 2 and 3).

Scheme 2.

Scheme 2

Dihydroxylation, hydroboration, and Buchwald-Hartwig amination.

Scheme 3.

Scheme 3

Reactions on compound 4.

Dihydroxylation of allyl-H-phosphinate 10 (Scheme 2) proceeds in good yield to afford diol 11. Compound 11 can be used to prepare phospholipid analogs, and this will be investigated in future work. Hydrolysis of 11 afforded H-phosphinate 12 in quantitative yield. Diol 12 was also oxidized using our catalytic process[3h] to afford phosphonic acid 13. Hydroboration/oxidation of 10 proceeded uneventfully to afford alcohol 14 in 71% yield. Another important reaction (Scheme 2) is the palladium-catalyzed cross-coupling of chloride 15. Buchwald-Hartwig amination took place in moderate yield to afford aniline derivative 16. Since H-phosphinates can undergo oxidation or cross-coupling, protection of the P-H functionality is necessary to perform these reactions.

A series of reactions was performed on ethyl cinnamyl-1,1-(diethoxy)ethyl-phosphinate 4 (Scheme 3). Unlike the sluggish hydrogenation of borane complexes (Eq 2), hydrogenation of 4 under standard conditions takes place in quantitative yield to produce 17. The presence of a phosphinylidene functionality P(O)H seems to be incompatible with hydrogenation as we have never been able to conduct the heterogeneous hydrogenation of H-phosphinic acids or esters, most likely because of complexation to Pd and poisoning of the catalyst. Hydroboration of 4 gave a mixture of regioisomers 18 (97% NMR yield) in low yield after chromatographic separation of each isomer (18a and 18b). On the other hand, epoxidation gave racemic 19 in moderate yield. Finally, Sharpless’ asymmetric dihydroxylation[13] gave the corresponding diol 20 in good yield. Interestingly, no kinetic resolution was observed in the formation of 20. As in Scheme 2, acidic hydrolysis delivered the diol 21 in quantitative yield and 59% ee. The absolute configuration was assigned based on the Sharpless-Corey models.[14] Enantiomeric excess determination was based on the formation of a diastereomeric salt with quinine and 31P-NMR analysis.

Another illustration of our strategy is an improved synthesis of a potent ATCase inhibitor (Ki = 0.42 μM, 27, Scheme 4).[11] Initially, we used the temporary protection strategy with cinnamyl-H-phosphinic acid (Eq 1), but since no purification was conducted, the benzoic acid side product required an adjustment in stoichiometry for the amidation step. Instead, we realized that isoprenylation would give volatile acetone after ozonolysis/reduction and so the reaction product would be cleaner and the subsequent yield higher. We have previously described the hydrophosphinylation of isoprene,[3n] and low catalyst loading can be employed. In spite of this, selection of our reusable polystyrene-supported catalyst[3l] for the hydrophosphinylation of isoprene was superior, resulting in a quantitative yield of product 22 after 5 runs of nixantphos-polymer 23 recycling (Scheme 4).

Scheme 4.

Scheme 4

Improved synthesis of ATCase inhibitor 27.

Isoprenyl-H-phosphinic acid 22 was protected according to method A (Table 1, entry 3) to produce 24. The synthesis of 22 and subsequently 24 is much more efficient and environmentally friendly than the alternative alkylation of 2 with isoprenyl halides (either through deprotonation or silylation of 2) would be (Scheme 1). Ozonolysis and oxidation of 24 with sodium chlorite[15] gave the corresponding carboxylic acid 25, which was used without intermediate isolation. Deprotection of the resulting amide 26 through hydrogenolysis of the benzyl groups, and acid hydrolysis of the acetal provided inhibitor 27 in good yield after ion-exchange chromatography.

Another application of building block 24, this time through an ozonolysis/Strecker sequence is shown in Scheme 5. Compound 28 could be hydrolyzed to the phosphino analog 29 of aspartic acid,[16] or it could be N-protected to 30, P-deprotected selectively, then cross-coupled to an aryl halide to form 32[17] after deprotection of intermediate 31.[18] This strategy could be applied to the combinatorial synthesis of other kynureninase inhibitors 32 by selecting other aryl halides for coupling.

Scheme 5.

Scheme 5

Syntheses of phosphinoaspartate analog 29 and kynureninase inhibitor 32.

Kynureninase inhibitors have potential for the blockage of quinolinic acid biosynthesis. Quinolinic acid has been implicated in various neurological disorders, such as epilepsy, Huntington’s disease, and AIDS-related dementia.[17] Thus, our method offers a flexible entry to prepare various analogs of 33 which could have useful biological activities.

graphic file with name nihms524481e3.jpg (3)

The last example of a reaction on protected phosphinic acid 10 is shown in Equation 3. Olefin metathesis of phosphorus-containing compounds,[19] as well as cross-metathesis of phosphonates[20] are known, but no example related to the cross-metathesis of phosphinic acids has ever been reported. Phosphinylidene containing compounds are not reactive partners in this reaction, but temporary protection clearly solves this problem. Cross-metathesis of 10 using the “second generation Grubbs’ catalyst” 34 afforded acrylate 33 in good yield.

Conclusions

The temporary protection of H-phosphinic acids has not been described previously. In spite of 20 years of successful uses of the Ciba-Geigy reagents, a more efficient approach to useful synthetic intermediates has been developed. This manuscript describes the synthesis of various temporarily protected H-phosphinic acids for the synthesis of more complex intermediates. Since numerous H-phosphinic acids are now readily available using various environmentally benign methodologies we have developed, the present strategy offers an attractive alternative to others previously described in the literature. For certain H-phosphinic acids which can be difficult to purify, this method also allows purification and esterification, so the purified ethyl H-phosphinate ester can be obtained easily after treatment with TMSCl/CHCl3. Even if P-diastereoselective reactions were not observed, and kinetic resolution could not be accomplished for the preparation of P-chiral compounds, the present approach should be useful to phosphorus chemists in general. From dihydroxylation, to cross-coupling, to cross-metathesis; the temporary protection of H-phosphinic acids as the corresponding acetals offers a new and efficient approach toward functional intermediates. Since deprotection of the 1,1-(diethoxy)ethyl group can deliver H-phosphinate esters or acids, a wide range of intermediates is accessible. Future work from our laboratory will investigate the synthesis of phospholipid analogs, and additional asymmetric reactions on protected phosphinates 6, as well as Tsuji-Trost type allylation reactions on unsaturated acetates.

Experimental Section

General procedure for the protection of H-phosphinates (Table 2, Method A)

To H-phosphinic acid or H-phosphinic acid ethyl ester (5.0 mmol, 1.0 equiv.) were added triethyl orthoacetate (5.5 mL, 30.0 mmol, 6.0 equiv.) and boron trifluoride diethyl ether (0.13 or 0.31 mL, 1.0 or 2.5 mmol, 0.2 or 0.5 equiv.) at r.t.. The reaction mixture was vigorously stirred for 16 – 24 h under N2 at r.t. to afford a yellow solution. The reaction mixture was diluted with ethyl acetate (50 mL) and washed with 0.5 M aqueous NaHCO3 (1 × 15 mL) then brine (2× 15 mL). The organic layer was dried with MgSO4 and concentrated in vacuo. The resulting oil was purified by chromatography over silica to afford the clean product.

(1,1-Diethoxy-ethyl)-cinnamyl-phosphinic acid ethyl ester 4 (Equation 1, Table 2, Entries 1a and 2a)

Method A, 0.2 eq. BF3•OEt2, 24 h, using cinnamyl-H-phosphinic acid.[21] Chromatography over silica gel (hexanes / ethyl acetate, 6/4, v/v) afforded 4 as a light yellow oil (1.3 g, 80 % yield). 1H NMR (300 MHz, CDCl3) δ: 7.20–7.38 (m, 5 H, aro CH), 6.53 (dd, 3JH,H = 16.0 Hz, 4JHCCCP = 4.0 Hz, 1 H, -CH=), 6.19–6.31 (m, 1 H, -CH=), 4.15–4.28 (m, 2 H, -CH2-O), 3.60–3.83 (m, 4 H, -CH2-O), 2.71–2.92 (m, 2 H, -CH2-P), 1.54 (d, 3JHCCP = 11.0 Hz, 3 H, CH3-C-P), 1.31 (t, J = 7.0 Hz, 3 H, CH3-), 1.22 (t, J = 7.0 Hz, 3 H, CH3-), 1.21 (t, 3JH,H = 7.0 Hz, 3 H, CH3-); 13C NMR (75.45 MHz, CDCl3) δ: 137.3, 134.8 (d, JPCCC = 12.0 Hz), 128.8 (2 C), 127.7, 126.4 (d, JPCCCCC = 1.5 Hz, 2 C), 119.1 (d, JPCC = 10.5 Hz), 101.5 (d, JPC = 139.0 Hz), 62.1 (d, JPOC = 7.0 Hz), 58.5 (d, JPCOC = 5.0 Hz), 57.0 (d, JPCOC = 7.0 Hz), 31.7 (d, JPC = 82.5 Hz), 20.8 (d, JPCC = 12.0 Hz), 17.0 (d, JPOCC = 5.0 Hz), 15.7, 15.5; 31P NMR (121.47 MHz, CDCl3) δ: 45.96 (s); HRMS (EI+) calcd. for C15H22O3P, ([M-OEt]+) 281.1307, found 281.1302.

(1,1-Diethoxy-ethyl)-(4-phenylamino-phenyl)-phosphinic acid ethyl ester 16 (Scheme 2)

In a sealed tube, K3PO4 (0.297 g, 1.4 mmol, 1.4 equiv.), Pd2dba3 (0.0092 g, 0.01 mmol, 4.0 mol-%) and 2-dicyclohexylphosphino-2′-(N,N-dimethylamino)biphenyl (0.017 g, 0.044 mmol, 4.4 mol-%) were added to the ester 15 (0.32 g, 1.0 mmol) in DME (2.0 mL) at r.t.. After 24 h at 100°C, the reaction mixture was cooled down and filtered through Celite®. The solution was concentrated in vacuo and the resulting oil was purified by chromatography over silica gel (hexanes / ethyl acetate, 4/6, v/v) to afford the amine 16 as a colorless oil (0.197 g, 52 %). 1H NMR (300 MHz, CDCl3) δ: 7.70 (dd, 3JH,H = 10.5 Hz, 3JH,H = 8.5 Hz, 2 H, aro CH), 7.30–7.36 (m, 2 H, aro CH), 7.18 (d, 3JH,H = 8.5 Hz, 2 H, aro CH), 7.02–7.08 (m, 3 H, aro CH), 4.02–4.26 (m, 2 H, -CH2-O), 3.56–3.80 (m, 4 H, -CH2-O), 1.45 (d, 3JHCCP = 12.0 Hz, 3 H, CH3-C-P), 1.34 (t, 3JH,H = 7.0 Hz, 3 H, CH3-), 1.19 (t, 3JH,H = 7.0 Hz, 3 H, CH3-), 1.18 (t, 3JH,H = 7.0 Hz, 3 H, CH3-); 13C NMR (75.45 MHz, CDCl3) δ: 148.1 (d, JPCCCC = 2.5 Hz), 141.4, 134.7 (d, JPCC = 10.5 Hz, 2 C), 129.5 (2 C), 122.8, 120.5 (2 C), 118.1 (d, JPC = 128.5 Hz), 114.9 (d, JPCCC = 13.0 Hz, 2 C), 101.6 (d, JPC = 153.5 Hz), 61.4 (d, JPOC = 7.0 Hz), 58.4 (d, JPCOC = 5.5 Hz), 58.0 (d, JPCOC = 7.0 Hz), 20.5 (d, JPCC = 13.0 Hz), 16.9 (d, JPOCC = 5.5 Hz), 15.8, 15.6; 31P NMR (121.47 MHz, CDCl3) δ: 36.74 (s); HRMS (EI+) calcd. for C20H28NO4P, ([M]+) 377.1756, found 377.1754.

Isoprenyl-H-phosphinic acid 22[3n] (Scheme 4, Table 2, Phosphinate, Entry 3): Synthesis with the polymer catalyst

In a sealed tube, isoprene (0.5 mL, 5.0 mmol, 1.0 equiv.) was added to concentrated H3PO2 (0.495 g, 7.5 mmol, 1.5 equiv.) in acetonitrile (10.0 mL, 0.5 M), followed by Pd2dba3 (0.023 g, 0.025 mmol, 0.5 mol-%) and polystyrene nixantphos catalyst 23[3l] (0.06 mmol, 1.2 mol-%). After the tube was sealed, the reaction was heated at 85 °C for 12–16 h. After cooling down, the reaction was filtered and the polymer recovered and used directly in another run. The combined filtrate from 5 reaction runs was concentrated in vacuo. The resulting crude was diluted with ethyl acetate (75 mL) and washed with brine (3 × 20 mL). The organic layer was dried with MgSO4 and concentrated in vacuo to afford 22 as a light yellow oil (3.34 g, 100 %). 1H NMR (CDCl3, 300 MHz) δ: 10.91 (bs, 1 H, OH), 6.94 (d, 1JHP = 550 Hz, 1 H, H-P), 5.13 (m, 1 H, -CH=), 2.57 (dd, 2JHCP = 19.0 Hz, 3JH,H = 8.0 Hz, 2 H, -CH2-P), 1.77 (d, 4JH,H = 4.0 Hz, 3 H, CH3-C=), 1.66 (d, 4JH,H = 4.0 Hz, 3 H, CH3-C=); 13C NMR (CDCl3, 75.45 MHz) δ: 138.4 (d, JPCCC = 14 Hz), 110.6 (d, JPCC = 9 Hz), 30.1 (d, JPC = 92 Hz), 25.8 (d, JPCCCC = 3 Hz), 18.2 (d, JPCCCC = 3 Hz); 31P NMR (CDCl3, 121.47 MHz) δ: 35.86 (dm, JPH = 550 Hz); HRMS (EI+) calcd. for C5H11O2P, ([M]+) 134.0497, found 134.0494.

(1,1-Diethoxy-ethyl)-(3-methyl-but-2-enyl)-phosphinic acid ethyl ester 24 (Scheme 4, Table 2, Entry 3)

Method A, 0.2 eq. BF3•OEt2, 24 h. Chromatography over silica gel (hexanes / ethyl acetate, 7/3, v/v) afforded 24 as a light yellow oil (0.89 g, 64 % yield). 1H NMR (300 MHz, CDCl3) δ: 5.22–5.29 (m, 1 H, -CH=), 4.12–4.26 (m, 2 H, -CH2-O), 3.62–3.83 (m, 4 H, -CH2-O), 2.59 (dd, 2JHCP = 15.5 Hz, 3JH,H = 8.0 Hz, 2 H, -CH2-P), 1.77 (d, 4JH,H = 4.0 Hz, 3 H, CH3-C=), 1.67 (d, 4JH,H = 4.0 Hz, 3 H, CH3-C=), 1.51 (d, 3JHCCP = 11.0 Hz, 3 H, CH3-C-P), 1.30 (t, 3JH,H = 7.0 Hz, 3 H, CH3-), 1.22 (t, 3JH,H = 7.0 Hz, 6 H, CH3-); 13C NMR (75.45 MHz, CDCl3) δ: 136.5 (d, JPCCC = 12.0 Hz), 112.6 (d, JPCC = 9.5 Hz), 101.4 (d, JPC = 137.0 Hz), 61.7 (d, JPOC = 7.0 Hz), 58.2 (d, JPCOC = 4.5 Hz), 57.7 (d, JPCOC = 7.0 Hz), 26.2 (d, JPC = 84.5 Hz), 25.9 (d, JPCCCC = 2.5 Hz), 20.6 (d, JPCC = 12.0 Hz), 18.1 (d, JPCCCC = 2.0 Hz), 16.7 (d, JPOCC = 5.5 Hz), 15.3, 15.6; 31P NMR (121.47 MHz, CDCl3) δ: 47.30 (s); HRMS (Ammonium Chem Ion) calcd. for C13H28O4P, ([M+H]+) 279.1725, found 279.1727.

(1,1-Diethoxy-ethyl)-(N-acetyl-L-aspartic acid dibenzyl ester)-phosphinic acid ethyl ester 26 (Scheme 4)

After saturation of a solution of the ester 24 (1.37 g, 4.93 mmol, 1.0 equiv.) in CH2Cl2 (0.2 M, 26.0 mL) at −78 °C with ozone, Me2S (2.5 mL, 33.5 mmol, 6.8 equiv.) was added under N2 at −78 °C. The reaction mixture was allowed to warm up to r.t. overnight, then the solution was concentrated in vacuo. The resulting oil was dissolved in a mixture tBuOH/H2O (2/1, v/v, 20 mL) and treated successively with 2-methyl-butene (0.5 M in THF, 9.8 mL, 9.8 mmol, 2.0 equiv.), NaH2PO4•H2O (1.0 g, 7.4 mmol, 1.5 equiv.) and NaClO2 (0.67 g, 3.4 mmol, 1.5 equiv.) at 0 °C. After 3 h at r.t., the reaction mixture was diluted with ethyl acetate (50 mL) and washed with 10% aqueous tartaric acid (2 × 15 mL). The aqueous layer was reextracted with ethyl acetate (1 × 20 mL). The combined organic layers were dried over MgSO4 and concentrated in vacuo to afford compound 25 which was used without further purification.

To a solution of the compound 25 (4.93 mmol, 1.0 equiv.) in distilled THF (0.2 M, 26 mL) was added L-aspartic acid dibenzyl ester p-toluenesulfonate (2.38 g, 4.9 mmol, 1.0 equiv.), Et3N (0.76 mL, 5.4 mmol, 1.1 equiv.), EDC•HCl (2.8 g, 14.7 mmol, 3.0 equiv.) and DMAP (2.38 g, 4.9 mmol, 3.0 equiv.). After 16 h at r.t. under N2, the reaction mixture was diluted with ethyl acetate (50 mL) and washed with 0.5 M aqueous HCl (1 × 10 mL) and brine (2 × 20 mL). The organic layer was dried over MgSO4 and concentrated in vacuo. The resulting oil was purified by chromatography over silica gel (hexanes / ethyl acetate, 6/4, v/v to ethyl acetate 100 %) to afford amide 26 as a lightly yellow oil (1.81 g, 66 % yield). 1H NMR (300 MHz, CDCl3) δ: 7.88 & 7.75 (2 d, 3JH,H = 8.0 Hz, 1 H, NH), 7.29–7.37 (m, 10 H, aro CH), 5.10 & 5.09 (2 d, 2JH,H = 12.0 Hz, 4 H, Bn -CH2-), 4.90–4.98 (m, 1 H, -CH-N), 4.13–4.5 (m, 2 H, -CH2-O), 3.59–3.81 (m, 4 H, -CH2-O), 2.74–3.08 (m, 4 H, -CH2- & -CH2-P), 1.49 (d, 3JHCCP = 12.0 Hz, 3 H, CH3-C-P), 1.17–1.37 (m, 9 H); 13C NMR (75.45 MHz, CDCl3) δ: 170.3, 170.1, 164.6 (2 d, JPCC = 8.5 Hz), 135.4, 135.2, 128.5 (2 C), 128.4 (2 C), 128.3, 101.0 (d, JPC = 150.5 Hz), 67.4, 66.8, 62.6 (2 d, JPOC = 8.0 Hz), 58.5 (2 d, JPCOC = 5.0 Hz), 57.9 (2 d, JPCOC = 8.0 Hz), 49.1 (d, JPCCNC = 10.5 Hz), 36.4 (d, JPCCNCC = 6.0 Hz), 34.6 & 34.5 (2 d, JPC = 72.0 Hz), 20.0 (d, JPCC = 13.0 Hz), 16.5 (2 d, JPOCC = 4.5 Hz), 15.3, 15.6; 31P NMR (121.47 MHz, CDCl3) δ: 42.77 & 42.70 (2 s); HRMS (Ammonium Chem Ion) calcd. for C28H38NO9P, ([M+H]+) 564.2362, found 564.2355.

(N-acetyl-L-aspartic acid)-H-phosphinic acid 27 (Scheme 4)

To a solution of amide 26 (1.0 g, 1.78 mmol) in a mixture THF/H2O (2/1, v/v, 5.1 mL) was added Pd/C (0.24 g, 10 wt%). The reaction was placed in a hydrogenator at 50 psi H2 and r.t.. After 17 h, the reaction mixture was filtered through Celite® and concentrated in vacuo. The resulting oil was dissolved in water (30 mL) and washed with CH2Cl2 (3 × 10 mL). The aqueous layer was concentrated then dissolved in a mixture THF/H2O (2/1, v/v, 12 mL) and treated with washed Amberlite IR-120 plus (0.83 g). The suspension was heated at 80 °C for 15 h under N2. After filtration, the reaction mixture was concentrated in vacuo. The resulting oil was dissolved in water, neutralized at pH 7.0 and purified by ion exchange over AG-1 X8 anion exchange resin (70 mL) which had been equilibrated with 100 mM Et3NH+HCO3 (pH 7.3). The column was washed with water (60 mL) then eluted with a linear gradient (200 mL + 200 mL, 100 – 500 mM) of Et3NH+HCO3 (pH 7.3). Fractions containing phosphorus compounds were identified by using the Pi assay developed by Ames22 and concentrated. The resulting white residue was dissolved in water, the solution passed through a Dowex H+ column, neutralized to pH 7 and then concentrated to afford H-phosphinic acid 27 as a light yellow oil (0.243 g, 57 % yield). 1H NMR (300 MHz, D2O) δ: 6.95 (d, 1JHP = 540.0 Hz, 1 H, H-P), 4.22 (dd, 3JH,H = 9.0 Hz, 3JH,H = 4.0 Hz, 1 H, -CH-N), 2.47–2.58 (m, 3 H, -CH2-P, -CH2-), 2.35 (dd, 2JH,H = 16.0 Hz, 3JH,H = 9.0 Hz, 1 H, -CH2-); 13C NMR (75.45 MHz, D2O) δ: 179.0, 178.8, 168.9, 53.6, 41.5 (d, JPC = 78.5 Hz), 39.8; 31P NMR (121.47 MHz, D2O) δ: 20.76 (dt, JPH = 539.5 Hz, JPCH =17.0 Hz); HRMS (ESI+) calcd. for C6H10O7NP, ([M+Na]+) 262.0093, found 262.0096.

(1,1-Diethoxy-ethyl)-(2-amino-2-cyano-ethyl)-phosphinic acid ethyl ester 28 (Scheme 5)

After saturation of a solution of the ester 24 (0.834 g, 3.0 mmol, 1.0 equiv.) in CH2Cl2 (0.2 M, 15.0 mL) at −78 °C with ozone, Me2S (1.5 mL, 20.4 mmol, 6.8 equiv.) was added under N2 at −78 °C. The reaction mixture was allowed to warm up to r.t. overnight then the solution was concentrated in vacuo. The resulting oil was dissolved in methanol (0.8 M, 4.0 mL) then added dropwise to a solution of sodium cyanide (0.25 g, 5.1 mmol, 1.7 equiv.), ammonium chloride (0.284 g, 5.4 mmol, 1.8 equiv.) in 25 % aqueous ammonium hydroxyde (1.0 M, 4.5 mL) at 0°C. The reaction mixture was kept at 0 °C for 1 h then at r.t. for 17 h. The reaction mixture was extracted with ether (3 × 50 mL) and the combined organic layers were washed with brine (2 × 20 mL). The organic layer was dried with MgSO4 and concentrated in vacuo to afford amine 28 as a colorless oil (0.566 g, 68 %). 2 diastereoisomers 54/46. 1H NMR (300 MHz, CDCl3) δ: 4.19–4.35 (m, 2 H + 1 H, -CH2-O & -CH-N), 3.63–3.84 (m, 4 H, -CH2-O), 1.94–2.49 (m, 2 H + 2 H, -CH2-P & NH2), 1.53 (2 d, 3JHCCP = 11.5 Hz, 3 H, CH3-C-P), 1.37 (t, 3JH,H = 7.0 Hz, 3 H, CH3-), 1.24 & 1.23 (2 t, 3JH,H = 7.0 Hz, 6 H, CH3-); 13C NMR (75.45 MHz, CDCl3) δ: 121.4 (d, JPCCC = 14.0 Hz) & 121.3 (d, JPCCC = 12.0 Hz), 101.3 (d, JPC = 147.0 Hz) & 101.2 (d, JPC = 146.0 Hz), 62.6 (d, JPOC = 6.5 Hz) & 62.4 (d, JPOC = 7.0 Hz), 58.8 (2 d, JPCOC = 5.5 Hz), 58.2 (d, JPCOC = 7.0 Hz) & 58.1 (d, JPCOC = 8.0 Hz), 38.9 (d, JPCC = 4.0 Hz) & 38.5 (d, JPCC = 3.5 Hz), 32.1 & 31.7 (2 d, JPC = 83.0 Hz), 20.1 (d, JPCC = 14.0 Hz) & 19.9 (d, JPCC = 12.5 Hz), 16.8 (d, JPOCC = 5.5 Hz), 15.7, 15.5 & 15.4; 31P NMR (121.47 MHz, CDCl3) δ: 44.87 (s, 54 %), 44.68 (s, 46 %).

(2-Benzyloxycarbonylamino-2-cyano-ethyl)-(1,1-diethoxy-ethyl)-phosphinic acid ethyl ester 30 (Scheme 5)

To amine 28 (1.2 g, 4.3 mmol) in THF (0.2 M, 22.0 mL) was added pyridine (0.42 mL, 5.18 mmol, 1.2 equiv.) followed by benzylchloroformate (0.61 mL, 4.13 mmol, 1.0 equiv.) at 0°C under N2. After 3 h at r.t., the reaction mixture was diluted with ethyl acetate (75 mL) and washed with brine (3 × 20 mL). The organic layer was dried with MgSO4 and concentrated in vacuo. The resulting oil was purified by chromatography over silica gel (hexanes / ethyl acetate, 7/3, v/v) to afford protected amine 30 as a colorless oil (1.58 g, 89 %). 1H NMR (300 MHz, CDCl3) δ: 7.35 (s, 5 H, aro CH), 6.83 (d, 3JH,H = 8.0 Hz, 0.54 H, NH), 6.49 (d, 3JH,H = 6.5 Hz, 0.46 H, NH), 5.14 (s, 2 H, Cbz -CH2-), 4.90–5.10 (m, 1 H, -CH-N), 4.08–4.35 (m, 2 H, -CH2-O), 3.55–3.82 (m, 4 H, -CH2-O), 2.23–2.52 (m, 2 H, -CH2-P), 1.51 & 1.48 (2 d, 3JHCCP = 11.5 Hz, 3 H, CH3-C-P), 1.34 & 1.30 (2 t, 3JH,H = 7.0 Hz, 3 H, CH3-), 1.17–1.23 (m, 6 H, CH3-); 13C NMR (75.45 MHz, CDCl3) δ: 155.2, 135.7, 128.5 (2 C), 128.3, 128.2 (2 C), 118.0 & 117.8 (2 d, JPCCC = 10.0 Hz), 100.9 (d, JPC = 148.5 Hz) & 100.8 (d, JPC = 148.0 Hz), 67.5, 62.7 & 62.6 (2 d, JPOC = 7.0 Hz), 58.8 & 58.7 (2 d, JPCOC = 5.5 Hz), 58.2 & 58.1 (2 d, JPCOC = 7.5 Hz), 38.0 (d, JPCC = 4.0 Hz), 28.9 & 27.9 (2 d, JPC = 82.0 Hz), 19.6 & 19.5 (2 d, JPCC = 12.0 Hz), 16.5 (2 d, JPOCC = 5.5 Hz), 15.4, 15.2 & 15.1; 31P NMR (121.47 MHz, CDCl3) δ: 45.75 (s, 54 %), 43.82 (s, 46 %); HRMS (Ammonium Chem Ion) calcd. for C19H30N2O6P, ([M+H]+) 413.1842, found 413.1839.

(2-Benzyloxycarbonylamino-2-cyano-ethyl)-phenyl-phosphinic acid ethyl ester 31 (Scheme 5)

To the acetal 30 (0.412 g, 1.0 mmol) in chloroform (0.1 M, 10.0 mL) was added chlorotrimethylsilane (0.25 mL, 2.0 mmol, 2.0 equiv.) at r.t. under N2. After 4 h, the reaction mixture was diluted with chloroform (50 mL) and washed with 0.5 M aqueous NaHCO3 (1 × 20 mL) and brine (2 × 20 mL). The organic layer was dried with MgSO4 and concentrated in vacuo to afford the H-phosphinic ethyl ester as a colorless oil, which was used without further purification. To the H-phosphinic ethyl ester in acetonitrile (0.1 M, 10.0 mL) was added diisopropylethylamine (0.23 mL, 1.3 mmol, 1.3 equiv.), iodobenzene (0.11 mL, 1.0 mmol, 1.0 equiv.) followed by Pd(OAc)2 (0.0045 mg, 0.02 mmol, 2.0 mol-%) and dppf (0.0122 mg, 0.022 mmol, 2.2 mol-%). After 2 h at reflux under N2, the reaction mixture was cooled down and another portion of Pd(OAc)2 (0.0045 mg, 0.02 mmol, 2.0 mol-%) and dppf (0.0122 mg, 0.022 mmol, 2.2 mol-%) was added. After a total of 16 h at reflux under N2, the reaction mixture was cooled down and concentrated in vacuo. The resulting oil was dissolved with ethyl acetate (50 mL) and washed with brine (3 × 20 mL). The organic layer was dried with MgSO4 and concentrated in vacuo. The resulting oil was purified by chromatography over silica gel (hexanes / ethyl acetate, 1/1, v/v) to afford the phosphinic acid ethyl ester 31 as a colorless oil (0.16 g, 43 %). 1H NMR (300 MHz, CDCl3) δ: 7.72–7.82 (m, 2 H, aro CH), 7.57–7.64 (m, 1 H, aro CH), 7.50–7.52 (m, 2 H, aro CH); 7.32–7.36 (m, 5 H, aro CH), 6.84 (d, 3JH,H = 6.5 Hz, 0.5 H, NH), 6.71 (d, 3JH,H = 6.5 Hz, 0.5 H, NH), 4.85–5.13 (m, 3 H, Cbz -CH2- & -CH-N), 3.83–4.19 (m, 2 H, -CH2-O), 2.22–2.66 (m, 2 H, -CH2-P), 1.32 & 1.29 (2 d, 3JH,H = 7.0 Hz, 3 H, CH3-); 13C NMR (75.45 MHz, CDCl3) δ: 155.4 & 155.3, 136.0 & 135.9, 133.5 (2 d, JPCCCC = 6.5 Hz), 132.0 & 131.7 (2 d, JPCC = 10.5 Hz, 2 C), 129.5 (d, JPC = 128.5 Hz), 129.3 & 129.2 (2 d, JPCCC = 13.0 Hz, 2 C), 128.8 (2 C), 128.6, 128.5 (2 C), 117.8 (d, JPCCC = 12.0 Hz) & 117.6 (d, JPCCC = 14.0 Hz), 67.7 (d, JPOC = 7.0 Hz), 62.0 & 61.8 (d, JPCC = 5.5 Hz), 38.3 & 38.2, 32.6 (d, JPC = 99.0 Hz) & 32.4 (d, JPC = 100.0 Hz), 16.6 (d, JPOCC = 6.0 Hz); 31P NMR (121.47 MHz, CDCl3) δ: 40.55 (s, 50 %), 39.79 (s, 50 %); HRMS (EI+) calcd. for C19H21N2O4P, ([M]+) 372.1239, found 372.1241.

2-Amino-3-(hydroxy-phenyl-phosphinoyl)-propionic acid hydrochloride 32[17] (Scheme 5)

A solution of phosphinate 31 (0.072 g, 0.19 mmol) in concentrated HCl (5.0 mL) was refluxed under nitrogen. After 20 h, the reaction mixture was cooled down and concentrated. The resulting oil was dissolved with water (30 mL) and washed with dichloromethane (3 × 10 mL). The aqueous layer was concentrated to afford phosphinic acid 32 (0.046 mg, 90 %). 1H NMR (300 MHz, D2O) δ: 7.56–7.63 (m, 2 H, aro CH), 7.34–7.48 (m, 3 H, aro CH), 3.98 (ddd, 3JHCCP = 15.0 Hz, 1 H, -CH-N), 2.36 (ddd, 2JHCP = 14.0 Hz, 2JH,H = 13.5 Hz, 3JH,H = 5.0 Hz, 1 H, -CH2-P), 2.13 (ddd, 2JHCP = 14.0 Hz, 2JH,H = 13.5 Hz, 3JH,H = 8.5 Hz, 1 H, -CH2-P); 13C NMR (75.45 MHz, D2O) δ: 171.1 (d, JPCCC = 11.0 Hz), 133.4 (d, JPC = 131.0 Hz),,132.3 (d, JPCCCC = 2.5 Hz), 131.0 (d, JPCC = 10.0 Hz, 2 C), 128.9 (d, JPCCC = 12.5 Hz, 2 C), 49.0, 30.7 (d, JPC = 92.0 Hz); 31P NMR (121.47 MHz, CDCl3) δ: 31.09 (s).

4-(But-2-enoic acid tert-butyl ester)-(1,1-diethoxy-ethyl)-phosphinic acid ethyl ester 33 (Equation 3)

To alkene 10 (0.25 g, 1.0 mmol) in dichloromethane (0.02 M, 20.0 mL) was added tert-butyl acrylate (0.44 mL, 3.0 mmol, 3.0 equiv.) and 2nd generation Grubbs catalyst 34 (0.042 g, 0.05 mmol, 5 mol-%) at r.t.. After 22 h, at reflux under N2, the reaction mixture was cooled down. Charcoal (2 g) was added and the suspension was filtered through Celite®. The solution was concentrated in vacuo. The resulting oil was purified by chromatography over silica gel (hexanes / ethyl acetate, 6/4, v/v) to afford ester 33 as a colorless oil (0.257 g, 73 %). 1H NMR (300 MHz, CDCl3) δ: 6.80–6.92 (m, 1 H, -CH=), 5.85–5.92 (m, 1 H, -CH=), 4.10–4.32 (m, 2 H, -CH2-O), 3.60–3.81 (m, 4 H, -CH2-O), 2.67–2.87 (m, 2 H, -CH2-P), 1.53 (d, 3JHCCP = 12.0 Hz, 3 H, CH3-C-P), 1.49 (s, 9 H, C(CH3)3), 1.34 (t, 3JH,H = 7.0 Hz, 3 H, CH3-), 1.23 (t, 3JH,H = 7.0 Hz, 3 H, CH3-), 1.22 (t, 3JH,H = 7.0 Hz, 3 H, CH3-); 13C NMR (75.45 MHz, CDCl3) δ: 165.2, 136.6 (d, JPCC = 9.0 Hz), 127.6 (d, JPCCC = 11.0 Hz), 101.5 (d, JPC = 143.0 Hz), 80.6, 62.2 (d, JPOC = 7.0 Hz), 58.5 (d, JPCOC = 4.5 Hz), 58.0 (d, JPCOC = 7.0 Hz), 31.1 (d, JPC = 80.0 Hz), 28.3, 20.5 (d, JPCC = 12.5 Hz), 16.8 (d, JPOCC = 5.0 Hz), 15.7, 15.4; 31 P NMR (121.47 MHz, CDCl3) δ: 44.57 (s); HRMS (Ammonium Chem Ion) calcd. for C16H32O6P, ([M+H]+) 351.1937, found 351.1941.

Supplementary Material

Supporting Information

Acknowledgments

We thank the National Institute of General Medical Sciences/NIH (1R01 GM067610) for the financial support of this research.

Footnotes

Supporting information for this article is available on the WWW under http://www.eurjoc.org/.

Supporting Information (see footnote on the first page of this article): General chemistry (1 page); procedures and spectral data (18 pages); 1H, 13C and 31P NMR spectra (135 pages).

References

  • 1.(a) Gallagher MJ, Honegger H. Tetrahedron Lett. 1977;18:2987–2990. [Google Scholar]; (b) Gallagher MJ, Honegger H. Aust J Chem. 1980;33:287–294. [Google Scholar]; (c) Dingwall JG, Ehrenfreund J, Hall RG, Jack J. Phosphorus Sulfur. 1987;30:571–574. [Google Scholar]; (d) Dingwall JG, Ehrenfreund J, Hall RG. Tetrahedron. 1989;45:3787–3808. [Google Scholar]; (e) Baylis EK. Tetrahedron Lett. 1995;36:9385–9388. [Google Scholar]; (f) Baylis EK. Tetrahedron Lett. 1995;36:9389–9392. [Google Scholar]; (g) Froestl W, Mickel SJ, Hall RG, von Sprecher G, Strub D, Baumann DPA, Brugger F, Gentsch C, Jaekel J, Olpe HR, Rihs G, Vassout A, Waldmeier PC, Bittiger H. J Med Chem. 1995;38:3297–3312. doi: 10.1021/jm00017a015. [DOI] [PubMed] [Google Scholar]
  • 2.For some representative examples, see: McCleery PP, Tuck B. J Chem Soc Perkin Trans I. 1989:1319–1329.Froestl W, Mickel SJ, von Sprecher G, Diel PJ, Hall RG, Maier L, Strub D, Melillo V, Baumann PA, Bernasconi R, Gentsch C, Hauser K, Jaekel J, Karlsson G, Klebs K, Maitre L, Marescaux C, Pozza MF, Schmutz M, Steinmann MW, van Riezen H, Vassout A, Mondadori C, Olpe HR, Waldmeier PC, Bittiger H. J Med Chem. 1995;38:3313–3331. doi: 10.1021/jm00017a016.Bennett SNL, Hall RG. J Chem Soc Trans 1. 1995:1145–1151.Belley M, Sullivan R, Reeves A, Evans J, O’Neill G, Ng GYK. Bioorg Med Chem. 1999;7:2697–2704. doi: 10.1016/s0968-0896(99)00214-x.Walker CV, Caravatti G, Denholm AA, Egerton J, Faessler A, Furet P, Garcia-Echeverria C, Gay B, Irving E, Jones K, Lambert A, Press NJ, Woods J. Bioorg Med Chem Lett. 2000;10:2343–2346. doi: 10.1016/s0960-894x(00)00476-5.Reck F, Marmor S, Fisherb S, Wuonolaa MA. Bioorg Med Chem Lett. 2001;11:1451–1454. doi: 10.1016/s0960-894x(01)00251-7.Hall RG, Riebli P. Phosphorus, Sulfur and Silicon. 2002;177:1557–1562.Yamagishi T, Miyamae T, Yokomatsu T, Shibuya S. Tetrahedron Lett. 2004;45:6713–6716.Prishchenko AA, Livantsov MV, Novikova OP, Livantsova LI. Russ J Gen Chem. 2006;76:1963–1965.Yamagishi T, Haruki T, Yokomatsu T. Tetrahedron. 2006;62:9210–9217.Yamagishi T, Haruki T, Yokomatsu T. Tetrahedron Asym. 2007;18:2886–2893.Abrunhosa-Thomas I, Sellers CE, Montchamp JL. J Org Chem. 2007;72:2851–2856. doi: 10.1021/jo062436o.Alstermark C, Amin K, Dinn SR, Elebring T, Fjellstrom O, Fitzpatrick K, Geiss WB, Gottfries J, Guzzo PR, Harding JP, Holmén A, Kothare Mohit, Lehmann A, Mattsson JP, Nilsson K, Sundén G, Swanson M, von Unge S, Woo AM, Wyle MJ, Zheng X. J Med Chem. 2008;51:4315–4320. doi: 10.1021/jm701425k.Zhang D, Yuan C. Chem Eur J. 2008;14:6049–6052. doi: 10.1002/chem.200800690.
  • 3.Reviews: Montchamp JL. Specialty Chemicals Magazine. 2006;26:44–46.Montchamp JL. J Organomet Chem. 2005;690:2388–2406.Coudray L, Montchamp J-L. Eur J Org Chem. 2008:3601–3613. doi: 10.1002/ejoc.200800331.Cross-Coupling: Montchamp JL, Dumond YR. J Am Chem Soc. 2001;123:510–511.Dumond YR, Montchamp JL. J Organomet Chem. 2002;653:252–260.Bravo-Altamirano K, Huang Z, Montchamp JL. Tetrahedron. 2005;61:6315–6329.Bravo-Altamirano K, Montchamp JL. Org Lett. 2006;8:4169–4171. doi: 10.1021/ol061828e.Bravo-Altamirano K, Montchamp JL. Tetrahedron Lett. 2007;48:5755–5759. doi: 10.1016/j.tetlet.2007.06.090.Coudray L, Montchamp JL. Eur J Org Chem. 2008:4101–4103. doi: 10.1002/ejoc.200800581.Hydrophosphinylation: Deprèle S, Montchamp JL. J Org Chem. 2001;66:6745–6755. doi: 10.1021/jo015876i.Deprèle S, Montchamp JL. J Am Chem Soc. 2002;124:9386–9387. doi: 10.1021/ja0261978.Deprèle S, Montchamp JL. Org Lett. 2004;6:3805–3808. doi: 10.1021/ol0484198.Ribière P, Bravo-Altamirano K, Antczak MI, Hawkins JD, Montchamp JL. J Org Chem. 2005;70:4064–4072. doi: 10.1021/jo050096l.Bravo-Altamirano K, Abrunhosa-Thomas I, Montchamp JL. J Org Chem. 2008;73:2292–2301. doi: 10.1021/jo702542a.
  • 4.Belabassi Y, Antczak MI, Tellez J, Montchamp JL. Tetrahedron. 2008;64:9181–9190. doi: 10.1016/j.tet.2008.07.054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Stano A, Mucha A, Kafarski P. Synth Commun. 1999;29:4269–4277. [Google Scholar]
  • 6.J.-L. Montchamp, unpublished results. The reaction of EtOP(O)H2 with ketene diethyl acetal in refluxing acetonitrile gives 2 in 70% yield. Of course, this method is not competitive with the original Ciba-Geigy synthesis of 2.
  • 7.Moskva VV, Maikova AI, Razumov AI. Russian J Gen Chem. 1969;39:595–599.Livantsov MV, Prishchenko AA, Lutsenko IF. Zh Obshch Khim. 1987;57:1042–1051.Endova M, Masojidkova M, Bucesinsky M, Rosenberg I. Tetrahedron Lett. 1996;37:3497–3500.Ebetino FH, Berk JD. J Organomet Chem. 1997;529:135–142.Luke GP, Shakespeare WC. Synth Commun. 2002;32:2951–2957.Prishchenko AA, Livantsov MV, Novikova ON, Livantsova LI, Koval’ Ya N, Grigor’ev EV. Russ J Gen Chem. 2004;74:1317–1320.(g) See also ref. 1c.
  • 8.Livantsov MV, Proskurnina MV, Prishchenko AA, Lutsenko IF. J Gen Chem USSR. 1984;54:2237–2249. [Google Scholar]
  • 9.Moskva VV, Maikova AI, Razumov AI. J Gen Chem USSR. 1969;39:2391–2393. [Google Scholar]
  • 10.Goldwhite H, Rowsell DG. J Am Chem Soc. 1966;88:3572–3577. doi: 10.1021/ja00967a019. [DOI] [PubMed] [Google Scholar]
  • 11.Coudray L, Kantrowitz ER, Montchamp JL. Bioorg Med Chem Lett. 2009;19:900–902. doi: 10.1016/j.bmcl.2008.11.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.The reactions between H-phosphinic acids and triethyl orthoacetate or triethyl orthoformate were investigated in our original esterification work. Since some P-C bond formation was observed, yet the yields of either H-phosphinate ester or acetal protected phosphinate were not very good and mixtures were obtained. This ultimately led to our discovery of the alkoxysilane-promoted esterification: Dumond YR, Baker RL, Montchamp JL. Org Lett. 2000;2:3341–3344. doi: 10.1021/ol006434g.
  • 13.Kolb HC, VanNieuwenhze MS, Sharpless KB. Chem Rev. 1994;94:2483–2547. [Google Scholar]
  • 14.(a) Nelson DW, Gypser A, Ho PT, Kolb HC, Kondo T, Kwong HL, McGrath DV, Rubin AE, Norrby PO, Gable KP, Sharpless KB. J Am Chem Soc. 1997;119:1840–1858. [Google Scholar]; (b) Corey EJ, Guzman-Perez A, Noe MC. J Am Chem Soc. 1995;117:10805–10816. [Google Scholar]
  • 15.Raach A, Reiser O. J Prakt Chem. 2000;342:605–608. [Google Scholar]
  • 16.Khomutov AR, Osipova TI, Khurs EN, Alferov KV, Khomutov RM. Russ Chem Bull. 1996;45:1961–1964.(b) See also ref. 1d.
  • 17.Ross FC, Botting NP, Leeson PD. Bioorg Med Chem Lett. 1996;6:2643–2646. [Google Scholar]
  • 18.Formation of aryl phosphinate 31 proceeds in low yield and was sluggish. The cross-coupling of H-phosphinate esters is known in the literature and typically uses 5 mol-% Pd or more. We elected to use dppf as the ligand since, in our hands, it gives better results than PPh3.
  • 19.For example: Reviews: McReynolds MD, Dougherty JM, Hanson PR. Chem Rev. 2004;104:2239–2258. doi: 10.1021/cr020109k.Diver ST, Giessert AJ. Chem Rev. 2004;104:1317–1382. doi: 10.1021/cr020009e.General: Nawara AJ, Shima T, Hampel F, Gladysz JA. J Am Chem Soc. 2006;128:4962–4963. doi: 10.1021/ja061044w.Dunne KS, Bisaro F, Odell B, Paris JM, Gouverneur V. J Org Chem. 2005;70:10803–10809. doi: 10.1021/jo0518708.Ogasawara M, Nagano T, Hayashi T. Organometallics. 2003;22:1174–1176.Ahmed M, Atkinson CE, Barrett AGM, Malagu K, Procopiou PA. Org Lett. 2003;5:669–672. doi: 10.1021/ol027406w.Sprott KT, McReynolds MD, Hanson PR. Org Lett. 2001;3:3939–3942. doi: 10.1021/ol016828n.Stoianova DS, Hanson PR. Org Lett. 2001;3:3285–3288. doi: 10.1021/ol016491p.Stoianova DS, Hanson PR. Org Lett. 2000;2:1769–1772. doi: 10.1021/ol005952o.Briot A, Bujard M, Gouverneur V, Nolan SP, Mioskowski C. Org Lett. 2000;2:1517–1519. doi: 10.1021/ol005651e.Allcock HR, Laredo WR, deDenus CR, Taylor JP. Macromolecules. 1999;32:7719–7725.Bujard M, Gouverneur V, Mioskowski C. J Org Chem. 1999;64:2119–2123. doi: 10.1021/jo981795j.Sieck SR, McReynolds MD, Schroeder CE, Hanson PR. J Organomet Chem. 2006;691:5307–5311.Coudray L, Bravo-Altamirano K, Montchamp JL. Org Lett. 2008;10:1123–1126. doi: 10.1021/ol8000415.(r) see also refs 3n.
  • 20.Cross-metathesis of phosphorus-containing compounds: Lera M, Hayes CJ. Org Lett. 2001;3:2765–2768. doi: 10.1021/ol016366d.Demchuk OM, Pietrusiewicz KM, Michrowska A, Grela K. Org Lett. 2003;5:3217–3220. doi: 10.1021/ol035011m.Chatterjee AK, Sanders DP, Grubbs RH. Org Lett. 2002;4:1939. doi: 10.1021/ol0259793.He A, Yan B, Thanavaro A, Spilling CD, Rath NP. J Org Chem. 2004;69:8643–8651. doi: 10.1021/jo0490090.
  • 21.Bravo-Altamirano K, Montchamp JL. Org Synth. 2008;85:96–105. [Google Scholar]
  • 22.Ames BN. Meth Enzymol. 1966;8:115–118. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES